M&A Analysis – Biotech – Oncology – October 2020 Oct 01, 2020 Immunomedic (IMMU) a notable deal in Biotech at a value of $21B and coming at a sizable 108% premium from Gilead (GILD) with M&A in... read more
M&A Analysis: Biotech M&A – July 2019 Jul 01, 2019 The Pfizer (PFE) deal for Array (ARRY) was one of the most interesting deals as it came at a strong 60% premium and options activity... read more